Carla Harmath to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Carla Harmath has written about Carcinoma, Hepatocellular.
Connection Strength
1.761
-
Beyond LI-RADS: Decoding the Prognostic Value of MRI Findings in HCC. Radiology. 2023 04; 307(2):e223309.
Score: 0.661
-
HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy. Abdom Radiol (NY). 2021 08; 46(8):3686-3697.
Score: 0.590
-
Congestive Hepatopathy: Pathophysiology, Workup, and Imaging Findings with Pathologic Correlation. Radiographics. 2024 May; 44(5):e230121.
Score: 0.180
-
Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdom Radiol (NY). 2021 08; 46(8):3698-3707.
Score: 0.147
-
Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatology. 2015 Oct; 62(4):1111-21.
Score: 0.097
-
Assessment of liver tumor response to therapy: role of quantitative imaging. Radiographics. 2013 Oct; 33(6):1781-800.
Score: 0.086